We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+2.94%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$8.76B
AUM Growth
+$49M
Cap. Flow
-$151M
Cap. Flow %
-1.72%
Top 10 Hldgs %
30.41%
Holding
420
New
31
Increased
183
Reduced
155
Closed
12

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$101M
2
SRE icon
Sempra
SRE
+$80.9M
3
ENB icon
Enbridge
ENB
+$74.4M
4
APD icon
Air Products & Chemicals
APD
+$69.7M
5
WMB icon
Williams Companies
WMB
+$66.6M

Top Sells

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$108M
2
GE icon
GE Aerospace
GE
+$103M
3
PNC icon
PNC Financial Services
PNC
+$103M
4
KO icon
Coca-Cola
KO
+$60.8M
5
ADI icon
Analog Devices
ADI
+$52.2M

Sector Composition

Rank Sector Weight
1 Technology 16.66%
2 Healthcare 16.48%
3 Financials 13.14%
4 Consumer Staples 12.39%
5 Industrials 11.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABB
301
DELISTED
ABB Ltd
ABB
$672K 0.01%
27,005
+13,650
+102% +$335K
GSK icon
302
GSK
GSK
$104B
$661K 0.01%
12,265
-1,600
-12% -$85.3K
MEDP icon
303
Medpace
MEDP
$16.1B
$635K 0.01%
21,915
-13,385
-38% -$375K
SGC icon
304
Superior Group of Companies
SGC
$185M
$633K 0.01%
+28,335
New +$551K
IFF icon
305
International Flavors & Fragrances
IFF
$20.2B
$628K 0.01%
4,652
MON
306
DELISTED
Monsanto Co
MON
$628K 0.01%
5,303
-951
-15% -$111K
SLP icon
307
Simulations Plus
SLP
$369M
$614K 0.01%
+49,710
New +$591K
COLM icon
308
Columbia Sportswear
COLM
$3.04B
$607K 0.01%
+10,445
New +$591K
COST icon
309
Costco
COST
$422B
$602K 0.01%
3,764
-350
-9% -$60.3K
C icon
310
Citigroup
C
$222B
$597K 0.01%
8,931
+2,200
+33% +$135K
CVG
311
DELISTED
Convergys
CVG
$562K 0.01%
23,648
SU icon
312
Suncor Energy
SU
$79.4B
$553K 0.01%
18,930
-1,114
-6% -$34.3K
TSM icon
313
TSMC
TSM
$2.1T
$553K 0.01%
15,815
-78
-0.5% -$2.7K
VOD icon
314
Vodafone
VOD
$36.3B
$542K 0.01%
18,882
-20,459
-52% -$570K
RF icon
315
Regions Financial
RF
$26.4B
$540K 0.01%
36,901
+4,979
+16% +$70.1K
ACET
316
DELISTED
Aceto Corp
ACET
$531K 0.01%
+34,330
New +$512K
BNS icon
317
Scotiabank
BNS
$107B
$526K 0.01%
8,750
+50
+0.6% +$2.87K
VYM icon
318
Vanguard High Dividend Yield ETF
VYM
$80.9B
$512K 0.01%
6,545
+25
+0.4% +$1.95K
CMP icon
319
Compass Minerals
CMP
$1.23B
$506K 0.01%
7,755
+290
+4% +$19.3K
PRU icon
320
Prudential Financial
PRU
$42.4B
$503K 0.01%
4,647
+642
+16% +$68.2K
HPQ icon
321
HP
HPQ
$24.9B
$488K 0.01%
27,918
-56
-0.2% -$1.03K
HPE icon
322
Hewlett Packard
HPE
$63.4B
$470K 0.01%
36,551
-12,715
-26% -$177K
MA icon
323
Mastercard
MA
$502B
$470K 0.01%
3,872
+1,552
+67% +$184K
COR icon
324
Cencora
COR
$60.6B
$464K 0.01%
4,910
-1,955
-28% -$174K
HEDJ icon
325
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
$462K 0.01%
+14,838
New +$481K

Similar funds

Bahl & Gaynor's Q2 2017 Portfolio in Review

As of Q2 2017, Bahl & Gaynor held 420 positions worth $8.76B, up 0.56% from $8.72B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Bahl & Gaynor's Q2 2017 filing shows 31 new, 183 increased, 155 reduced and 12 closed positions. Its largest new stake was Williams Companies: 2,234,345 shares worth $67.7M. The largest sale was Occidental Petroleum, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2017 buy was Williams Companies: 2,234,345 shares worth $67.7M.
  • Bahl & Gaynor added most to Texas Instruments in Q2 2017, an estimated $101M increase.
  • Bahl & Gaynor's biggest Q2 2017 reduction was Occidental Petroleum, cutting an estimated $108M.
  • Bahl & Gaynor fully exited Qualcomm in Q2 2017, selling an estimated $33.3M.
  • Bahl & Gaynor's ten largest holdings make up 30% of its $8.76B portfolio in Q2 2017.
  • Bahl & Gaynor opened 31 new positions and closed 12 in Q2 2017.
  • Bahl & Gaynor's portfolio value rose 0.56% quarter-over-quarter to $8.76B.

Based on Bahl & Gaynor's 13F filing for Q2 2017, filed 10 Aug 2017.